Epstein-Barr-virus-related malignant B cell lymphoplasmacytic lymphoma following allogeneic bone marrow transplantation for aplastic anemia

Transplantation. 1987 Aug;44(2):244-9. doi: 10.1097/00007890-198708000-00014.

Abstract

The development of B cell lymphoma has been reported to occur in recipients of a variety of organ transplants, including some patients who have received an allogeneic bone marrow graft. In this report, we describe a patient with severe aplastic anemia who developed a malignant B cell lymphoplasmacytoid proliferation 48 days after undergoing allogeneic marrow transplantation from her HLA-matched MLC-nonreactive brother. Immunologic studies showed this malignancy to be a mixed polyclonal and monoclonal proliferation in donor cells. Virologic studies documented Epstein Barr infection of the cells. A review of the literature suggests that graft-versus-host disease and treatment of this complication by antithymocyte globulin are related to the development of the EBV-related malignancy in the EBV-infected B cells of the developing bone marrow graft.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Anemia, Aplastic / complications*
  • Antibodies, Viral / analysis
  • Antigens, Viral / immunology
  • B-Lymphocytes / pathology
  • Bone Marrow Transplantation*
  • Capsid / immunology
  • Epstein-Barr Virus Nuclear Antigens
  • Female
  • Genes
  • Herpesvirus 4, Human / immunology
  • Humans
  • Immunoglobulin kappa-Chains / genetics
  • Lymphoma / etiology*
  • Lymphoma / immunology
  • Lymphoma / microbiology
  • Lymphoma / pathology

Substances

  • Antibodies, Viral
  • Antigens, Viral
  • Epstein-Barr Virus Nuclear Antigens
  • Immunoglobulin kappa-Chains